Literature DB >> 18941734

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

D M Nathan1, J B Buse, M B Davidson, E Ferrannini, R R Holman, R Sherwin, B Zinman.   

Abstract

The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm published in January 2008 specifically addressed safety issues surrounding the thiazolidinediones. In this revision, we focus on the new classes of medications that now have more clinical data and experience.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941734     DOI: 10.1007/s00125-008-1157-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  89 in total

Review 1.  Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review.

Authors:  Laura M C Welschen; Evelien Bloemendal; Giel Nijpels; Jacqueline M Dekker; Robert J Heine; Wim A B Stalman; Lex M Bouter
Journal:  Diabetes Care       Date:  2005-06       Impact factor: 19.112

2.  A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin.

Authors:  Azim S Gangji; Tali Cukierman; Hertzel C Gerstein; Charles H Goldsmith; Catherine M Clase
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

3.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors:  Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

4.  A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.

Authors:  P Damsbo; P Clauson; T C Marbury; K Windfeld
Journal:  Diabetes Care       Date:  1999-05       Impact factor: 19.112

5.  Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

Authors:  Philip Raskin; Elsie Allen; Priscilla Hollander; Andrew Lewin; Robert A Gabbay; Peter Hu; Bruce Bode; Alan Garber
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

6.  Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Authors:  David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

7.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

8.  U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.

Authors: 
Journal:  Diabetes       Date:  1995-11       Impact factor: 9.461

9.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.

Authors:  P Reichard; B Y Nilsson; U Rosenqvist
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

10.  The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

Authors: 
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

View more
  214 in total

Review 1.  The pharmacogenetics of metformin.

Authors:  Jose C Florez
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

2.  Single-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant.

Authors:  Jeffrey J Gaynor; Gaetano Ciancio; Giselle Guerra; Junichiro Sageshima; Lois Hanson; David Roth; Michael J Goldstein; Linda Chen; Warren Kupin; Adela Mattiazzi; Lissett Tueros; Sandra Flores; Luis J Barba; Adrian Lopez; Jose Rivas; Phillip Ruiz; Rodrigo Vianna; George W Burke
Journal:  Diabetologia       Date:  2014-11-01       Impact factor: 10.122

3.  Choice of long-acting insulin therapy for type 2 diabetes: how can treatment for older people be optimized?

Authors:  Andrew J Krentz; Alan J Sinclair
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

4.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

5.  Controversy about the relative efficacy of dipeptidyl peptidase IV inhibitors.

Authors:  A J Scheen
Journal:  Diabetologia       Date:  2012-07-07       Impact factor: 10.122

6.  The American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) algorithm for managing glycaemia in patients with type 2 diabetes mellitus: comparison with the ADA/EASD algorithm.

Authors:  H W Rodbard; P S Jellinger
Journal:  Diabetologia       Date:  2010-09-12       Impact factor: 10.122

7.  Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes.

Authors:  J J Nolan
Journal:  Diabetologia       Date:  2010-04-25       Impact factor: 10.122

8.  Should the algorithm for the treatment of type 2 diabetes be evidence-based?

Authors:  P-J Guillausseau
Journal:  Diabetologia       Date:  2010-07-07       Impact factor: 10.122

Review 9.  Evidence-based and heuristic approaches for customization of care in cardiometabolic syndrome after spinal cord injury.

Authors:  Mark S Nash; Rachel E Cowan; Jochen Kressler
Journal:  J Spinal Cord Med       Date:  2012-09       Impact factor: 1.985

10.  Metformin use and its effect on gastric cancer in patients with type 2 diabetes: A systematic review of observational studies.

Authors:  Peiwen Li; Cong Zhang; Peng Gao; Xiaowan Chen; Bin Ma; Dehao Yu; Yongxi Song; Zhenning Wang
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.